Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016601 |
4-hydroxytamoxifen |
4-hydroxytamoxifen results in increased expression of DRD1 mRNA | increases expression | 19901195
|
C077358 |
7-benzylidenenaltrexone |
7-benzylidenenaltrexone binds to and results in decreased activity of DRD1 protein | affects binding|decreases activity | 19482038
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY1 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY2 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY3 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY4 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY5 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY6 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY7 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY8 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D002220 |
Carbamazepine |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY9 protein] | affects binding|decreases reaction|increases activity | 19922557
|
D003024 |
Clozapine |
Clozapine binds to DRD1 protein | affects binding | 11997696
|
D003024 |
Clozapine |
DRD1 gene polymorphism affects the susceptibility to Clozapine | affects response to substance | 17092969
|
D003024 |
Clozapine |
DRD1 protein affects the susceptibility to Clozapine | affects response to substance | 17092969
|
D003024 |
Clozapine |
Clozapine analog binds to DRD1 protein | affects binding | 11997696
|
D018818 |
Fenoldopam |
Fenoldopam binds to and results in increased activity of DRD1 protein | affects binding|increases activity | 19406658
|
D006220 |
Haloperidol |
Haloperidol binds to DRD1 protein | affects binding | 16983399
|
D008094 |
Lithium |
DRD1 gene polymorphism affects the susceptibility to Lithium | affects response to substance | 19153942
|
D008094 |
Lithium |
DRD1 protein results in increased susceptibility to Lithium | increases response to substance | 19153942
|
C534628 |
SCH 23390 |
SCH 23390 binds to and results in decreased activity of DRD1 protein | affects binding|decreases activity | 19482038
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY1 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY2 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY3 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY4 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY5 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY6 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY7 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY8 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
Carbamazepine inhibits the reaction [[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY9 protein] | affects binding|decreases reaction|increases activity | 19922557
|
C071262 |
SK&F 82958 |
SK&F 82958 binds to and results in increased activity of DRD1 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY1 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY2 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY3 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY4 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY5 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY6 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY7 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY8 protein | affects binding|increases activity | 19922557
|
C071262 |
SK&F 82958 |
[SK&F 82958 binds to and results in increased activity of DRD1 protein] which results in increased activity of ADCY9 protein | affects binding|increases activity | 19922557
|
C094142 |
TAN 67 |
TAN 67 binds to and results in increased activity of DRD1 protein | affects binding|increases activity | 19482038
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of DRD1 mRNA | increases expression | 19901195
|
D015647 |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine binds to and results in increased activity of DRD1 protein | affects binding|increases activity | 15725338
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Carbamazepine |
9.22 | 8986270 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.22 | 15322242 11752688 14514962 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.53 | 16835633 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.19 | 14617031 12649775 16160616 |
MESH:D000544 |
Alzheimer Disease |
|
Lithium |
3.48 | 19621015 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D000855 |
Anorexia |
|
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine |
6.01 | 12183048 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 18205172 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.73 | 19368416 18080171 |
MESH:D001714 |
Bipolar Disorder |
marker/mechanism |
|
| 19153942 |
MESH:D001714 |
Bipolar Disorder |
|
Carbamazepine |
8.18 | 20046352 17594078 |
MESH:D001714 |
Bipolar Disorder |
|
Lithium |
8.18 | 17594078 20046352 20338123 19153942 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.15 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.70 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18670907 18850075 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
5.06 | 15215559 1977408 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 12621046 15668235 16354765 8697196 15340226 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.10 | 17123785 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Carbamazepine |
2.89 | 9014606 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 20055451 15322242 10048152 |
MESH:D007644 |
Darier Disease |
|
Lithium |
6.06 | 20338123 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.96 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.69 | 11575062 |
MESH:D018500 |
Diabetes Insipidus, Nephrogenic |
|
Lithium |
5.88 | 19244398 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.59 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.59 | 17107852 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.73 | 15331141 |
OMIM:607208 |
DRAVET SYNDROME |
|
Carbamazepine |
5.58 | 11748493 |
MESH:D004342 |
Drug Hypersensitivity |
|
Carbamazepine |
4.47 | 16538176 20216337 15057820 16538175 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbamazepine |
4.26 | 17465707 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
4.26 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Carbamazepine |
8.67 | 20216337 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.67 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
4.26 | 16402076 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.48 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Carbamazepine |
4.86 | 17654737 |
MESH:D016889 |
Endometrial Neoplasms |
|
4-hydroxytamoxifen |
4.19 | 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Carbamazepine |
5.38 | 19915237 18855540 16538176 20485159 16415921 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Carbamazepine |
5.35 | 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Carbamazepine |
5.15 | 15008574 16628512 17116037 |
MESH:D004827 |
Epilepsy |
|
Carbamazepine |
4.04 | 7988514 9014606 18234410 19620853 20417680 17465707 17178248 19700373 19439326 821787 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Carbamazepine |
5.49 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Carbamazepine |
5.27 | 15276670 3659116 |
MESH:D004916 |
Erythromelalgia |
|
Carbamazepine |
5.88 | 19549232 |
MESH:D005076 |
Exanthema |
|
Carbamazepine |
5.62 | 20485159 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Lithium |
7.20 | 19638421 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
7.20 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.03 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 15340226 18606429 16354765 16959395 8697196 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Carbamazepine |
4.82 | 10459572 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
5.06 | 16046005 |
MESH:D006965 |
Hyperplasia |
|
Carbamazepine |
5.35 | 18773962 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.91 | 12878042 12200463 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.04 | 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
1.75 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.17 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.24 | 11884234 19555203 |
MESH:D008180 |
Lupus Erythematosus, Systemic |
|
Carbamazepine |
3.59 | 16628512 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
8.88 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
8.88 | 16856516 |
MESH:D008607 |
Mental Retardation |
|
Carbamazepine |
3.76 | 9014606 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.50 | 19142101 |
MESH:D009203 |
Myocardial Infarction |
|
Lithium |
3.96 | 16288908 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D009224 |
Myotonia Congenita |
|
Carbamazepine |
5.62 | 20399394 |
MESH:D009421 |
Nervous System Malformations |
|
Carbamazepine |
10.36 | 16990009 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.36 | 14600291 |
MESH:D009765 |
Obesity |
|
Clozapine |
3.04 | 19142110 18515891 |
MESH:D010018 |
Osteomalacia |
|
Carbamazepine |
5.62 | 17016548 |
MESH:D010146 |
Pain |
|
Carbamazepine |
4.12 | 15215642 |
MESH:D010267 |
Parapsoriasis |
|
Carbamazepine |
5.84 | 16538176 |
OMIM:167400 |
PAROXYSMAL EXTREME PAIN DISORDER |
|
Carbamazepine |
6.08 | 17145499 17679678 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011248 |
Pregnancy Complications |
|
Carbamazepine |
5.29 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Carbamazepine |
10.37 | 9014606 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
10.37 | 11896295 11118676 11399792 11222880 |
MESH:D019310 |
Pseudolymphoma |
|
Carbamazepine |
5.77 | 12752131 9591791 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
5.09 | 11575062 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.42 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.42 | 11575062 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012559 |
Schizophrenia |
marker/mechanism |
|
| 18583979 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
4.15 | 18806925 20521326 20521320 20107430 11151749 20452607 20168265 18855531 20580759 17726453 16141801 11763009 17123785 17667964 19369910 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
4.15 | 20107430 19369910 1830565 18513383 |
MESH:D012640 |
Seizures |
|
Carbamazepine |
7.11 | 15946322 9046859 16180713 16938433 19414003 9844417 16876388 |
MESH:D012640 |
Seizures |
|
Lithium |
7.11 | 19660546 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.09 | 16192470 |
MESH:D012893 |
Sleep Disorders |
|
Carbamazepine |
5.27 | 19414003 |
MESH:D013226 |
Status Epilepticus |
|
Lithium |
5.96 | 19951488 19570321 19430551 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Carbamazepine |
5.35 | 19694795 15057820 16415921 16538176 18855540 20485159 19915237 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
4.83 | 20210726 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
4.57 | 16402076 20564506 20521320 16141801 20107430 17502770 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.23 | 17933447 |